The Efficacy and Toxicity of Aggressive Thoracic Radiotherapy for Stage Ⅳ Non-Small Cell Lung Cancer Patients With Controlled Extrathoracic Disease View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2018-2023

ABSTRACT

This phase II trial studies the safety and efficacy of aggressive thoracic radiotherapy in treating patients with non-small cell lung cancer that has not progressed after the first line systemic therapy. In this trial, patients with stage Ⅳ non small cell lung cancer who did not progress after first line systemic therapy will receive the aggressive thoracic radiotherapy, and the safety and efficacy of aggressive thoracic radiotherapy will be evaluated. The primary end points of the study are overall survival (OS), the secondary end points are local control rate, local progression free survival(LPFS), PFS, and toxicity and quality of life(QOL). More... »

URL

https://clinicaltrials.gov/show/NCT03565120

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "This phase II trial studies the safety and efficacy of aggressive thoracic radiotherapy in treating patients with non-small cell lung cancer that has not progressed after the first line systemic therapy. In this trial, patients with stage \u2163 non small cell lung cancer who did not progress after first line systemic therapy will receive the aggressive thoracic radiotherapy, and the safety and efficacy of aggressive thoracic radiotherapy will be evaluated. The primary end points of the study are overall survival (OS), the secondary end points are local control rate, local progression free survival(LPFS), PFS, and toxicity and quality of life(QOL).", 
    "endDate": "2023-08-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT03565120", 
    "keywords": [
      "efficacy", 
      "toxicity", 
      "non-small cell lung cancer patient", 
      "disease", 
      "phase II trial", 
      "safety", 
      "radiotherapy", 
      "patient", 
      "Non-Small-Cell Lung Carcinoma", 
      "systemic therapy", 
      "trial", 
      "non small cell lung cancer", 
      "progress", 
      "primary end point", 
      "overall survival", 
      "Secondary end point", 
      "local control", 
      "progression-free", 
      "Pf", 
      "quality life", 
      "quality of life"
    ], 
    "name": "The Efficacy and Toxicity of Aggressive Thoracic Radiotherapy for Stage \u2163 Non-Small Cell Lung Cancer Patients With Controlled Extrathoracic Disease", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT03565120"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:27", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00027.json", 
    "sponsor": [
      {
        "id": "https://www.grid.ac/institutes/grid.459671.8", 
        "type": "Organization"
      }
    ], 
    "startDate": "2018-08-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "sg:pub.10.1186/s12885-016-2952-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002909486", 
          "https://doi.org/10.1186/s12885-016-2952-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12885-016-2952-3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1002909486", 
          "https://doi.org/10.1186/s12885-016-2952-3"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2014.07.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1003563094"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/1759-7714.12305", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1006928183"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1586/era.10.22", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1011269382"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/1471-2407-13-474", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1019284464", 
          "https://doi.org/10.1186/1471-2407-13-474"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.prro.2015.07.009", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1023528607"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1371/journal.pone.0145936", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1034784095"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1200/jco.2007.15.3312", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1040085264"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.ijrobp.2007.12.031", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1050743671"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT03565120"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT03565120'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT03565120'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT03565120'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT03565120'


 

This table displays all metadata directly associated to this object as RDF triples.

69 TRIPLES      16 PREDICATES      45 URIs      30 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT03565120 schema:about anzsrc-for:3142
2 schema:description This phase II trial studies the safety and efficacy of aggressive thoracic radiotherapy in treating patients with non-small cell lung cancer that has not progressed after the first line systemic therapy. In this trial, patients with stage Ⅳ non small cell lung cancer who did not progress after first line systemic therapy will receive the aggressive thoracic radiotherapy, and the safety and efficacy of aggressive thoracic radiotherapy will be evaluated. The primary end points of the study are overall survival (OS), the secondary end points are local control rate, local progression free survival(LPFS), PFS, and toxicity and quality of life(QOL).
3 schema:endDate 2023-08-01T00:00:00Z
4 schema:keywords Non-Small-Cell Lung Carcinoma
5 Pf
6 Secondary end point
7 disease
8 efficacy
9 local control
10 non small cell lung cancer
11 non-small cell lung cancer patient
12 overall survival
13 patient
14 phase II trial
15 primary end point
16 progress
17 progression-free
18 quality life
19 quality of life
20 radiotherapy
21 safety
22 systemic therapy
23 toxicity
24 trial
25 schema:name The Efficacy and Toxicity of Aggressive Thoracic Radiotherapy for Stage Ⅳ Non-Small Cell Lung Cancer Patients With Controlled Extrathoracic Disease
26 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT03565120
27 schema:sdDatePublished 2019-03-07T15:27
28 schema:sdLicense https://scigraph.springernature.com/explorer/license/
29 schema:sdPublisher N2ece405fff4842aaad4ce02e8776a96e
30 schema:sponsor https://www.grid.ac/institutes/grid.459671.8
31 schema:startDate 2018-08-01T00:00:00Z
32 schema:subjectOf sg:pub.10.1186/1471-2407-13-474
33 sg:pub.10.1186/s12885-016-2952-3
34 https://doi.org/10.1016/j.ijrobp.2007.12.031
35 https://doi.org/10.1016/j.ijrobp.2014.07.012
36 https://doi.org/10.1016/j.prro.2015.07.009
37 https://doi.org/10.1111/1759-7714.12305
38 https://doi.org/10.1200/jco.2007.15.3312
39 https://doi.org/10.1371/journal.pone.0145936
40 https://doi.org/10.1586/era.10.22
41 schema:url https://clinicaltrials.gov/show/NCT03565120
42 sgo:license sg:explorer/license/
43 sgo:sdDataset clinical_trials
44 rdf:type schema:MedicalStudy
45 N2ece405fff4842aaad4ce02e8776a96e schema:name Springer Nature - SN SciGraph project
46 rdf:type schema:Organization
47 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
48 rdf:type schema:DefinedTerm
49 sg:pub.10.1186/1471-2407-13-474 schema:sameAs https://app.dimensions.ai/details/publication/pub.1019284464
50 https://doi.org/10.1186/1471-2407-13-474
51 rdf:type schema:CreativeWork
52 sg:pub.10.1186/s12885-016-2952-3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1002909486
53 https://doi.org/10.1186/s12885-016-2952-3
54 rdf:type schema:CreativeWork
55 https://doi.org/10.1016/j.ijrobp.2007.12.031 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050743671
56 rdf:type schema:CreativeWork
57 https://doi.org/10.1016/j.ijrobp.2014.07.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1003563094
58 rdf:type schema:CreativeWork
59 https://doi.org/10.1016/j.prro.2015.07.009 schema:sameAs https://app.dimensions.ai/details/publication/pub.1023528607
60 rdf:type schema:CreativeWork
61 https://doi.org/10.1111/1759-7714.12305 schema:sameAs https://app.dimensions.ai/details/publication/pub.1006928183
62 rdf:type schema:CreativeWork
63 https://doi.org/10.1200/jco.2007.15.3312 schema:sameAs https://app.dimensions.ai/details/publication/pub.1040085264
64 rdf:type schema:CreativeWork
65 https://doi.org/10.1371/journal.pone.0145936 schema:sameAs https://app.dimensions.ai/details/publication/pub.1034784095
66 rdf:type schema:CreativeWork
67 https://doi.org/10.1586/era.10.22 schema:sameAs https://app.dimensions.ai/details/publication/pub.1011269382
68 rdf:type schema:CreativeWork
69 https://www.grid.ac/institutes/grid.459671.8 schema:Organization
 




Preview window. Press ESC to close (or click here)


...